返回
S
Srinivas R. Sadda
Doheny Eye Institute
96H指数
1.1K论文数
3.5W被引数
收录论文 294
发表时间
A Randomised-controlled trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in patients with Chronic Central Serous Chorioretinopathy with persistent fluid in the absence of choroidal neovascular membrane – BRICS trial Report II一项关于Brolucizumab玻璃体内注射在持续性液体且无脉络膜新生血管膜的慢性中心性浆液性脉络膜视网膜病变患者中的疗效、安全性和耐受性的随机对照试验——BRICS试验报告II

